James L. Tyree, Executive Vice President at ABBOTT LABORATORIES (ABT), sold 8,833 shares at $54.10 ($481K) on 2009-02-17, disclosed to the SEC on 2009-02-19.
Scheduled sale ($481k) by Executive Vice President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $54.09 | 4,661 | $252K | 52.5% |
| 2 | $54.10 | 904 | $49K | 10.2% |
| 3 | $54.94 | 3,268 | $180K | 37.4% |
| Total | $54.41 avg | 8,833 | $481K | 100% |
| Filing → |
| ASRT | SELL | 2024-03-15 | $11K | — | Filing → |
| GNLX | SELL | 2023-12-14 | $192K | — | Filing → |
| ASRT | SELL | 2023-05-05 | $259K | — | Filing → |